Search

30/08/2024 Colchicine in acutely decompensated heart failure: the COLICA trial
Pascual-Figal, D, Núñez, J, Pérez-Martínez, MT, González-Juanatey, JR, Taibo-Urquia, M, Llàcer-Iborra, P, Delgado, J, Villar, S, Mirabet, S, Aimo, A, Riquelme-Pérez, A, Anguita-Sánchez, M, Martínez-Sellés, M, Noguera-Velasco, JA, Ibáñez, B, Bayés-Genís, A. Colchicine in acutely decompensated heart failure: the COLICA trial. EUROPEAN HEART JOURNAL. 2024; DOI:10.1093/eurheartj/ehae538. PMID:39211951. IF:35.600(Q1/1D).
01/02/2026 Temporary mechanical support in fulminant myocarditis: prognostic factors and clinical implications from the FULLMOON study
Schmidt, M, Ponnaiah, M, Huang, F, Montero, S, Raimbault, V, Abrams, D, Lebreton, G, Pellegrino, V, Ihle, J, Bottiroli, M, Persichini, R, Barrionuevo-Sánchez, MI, Solé, AA, Ng, PY, Ching, SSW, Ayer, R, Buscher, H, Biendel, C, Delmas, C, Ferreira, R, Roncon-Albuquerque, R Jr, López-Sobrino, T, Bunge, JJH, Fisser, C, Franchineau, G, McCanny, J, Ohshimo, S, Sionis, A, Hernández-Pérez, FJ, Barge-Caballero, E, Balik, M, Muglia, H, Park, S, Donker, DW, Porral, B, Aïssaoui, N, Dessap, AM, Burgos, V, Lesouhaitier, M, Fried, J, Jung, JS, Rosillo, S, Scherrer, V, Nseir, S, Winszewski, H, Jorge-Pérez, P, Kimmoun, A, Diaz, R, Hekimian, G, Ammirati, E, Combes, A. Temporary mechanical support in fulminant myocarditis: prognostic factors and clinical implications from the FULLMOON study. INTENSIVE CARE MEDICINE. 2026; 52(2)DOI:10.1007/s00134-025-08268-3. PMID:41524796. IF:21.200(Q1/1D).
01/01/2026 Haemodynamic monitoring and management of the hypotensive out-of-hospital cardiac arrest patient in the adult intensive care unit: a clinical consensus statement of the Association for Acute CardioVascular Care of the ESC
Grand, J, Sionis, A, Hassager, C, Perez, PJ, Poess, J, Schaubroeck, H, Desch, S, Krychtiuk, KA, Belohlavek, J, Mebazaa, A, Huber, K, van Diepen, S, Vandenbriele, C, Morrow, D, Tavazzi, G. Haemodynamic monitoring and management of the hypotensive out-of-hospital cardiac arrest patient in the adult intensive care unit: a clinical consensus statement of the Association for Acute CardioVascular Care of the ESC. European Heart Journal-Acute Cardiovascular Care. 2026; 15(1)DOI:10.1093/ehjacc/zuaf125. PMID:41014602. IF:4.600(Q1/2D).
23/12/2025 Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure: The ANDES Randomized Clinical Trial
Rodés-Cabau, J, Nombela-Franco, L, Cruz-Gonzalez, I, Hibbert, B, Freixa, X, Masson, JB, Ibrahim, R, Estevez-Loureiro, R, Millan, X, Kass, M, Paradis, JM, Champagne, J, Salinas, P, Laffond, A, Abdel-Razek, O, Labinaz, M, Cepas-Guillen, P, Arzamendi, D, Vidal-Cales, P, Pavesi, M, Côté, M, O'Hara, G, Salaun, E. Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure: The ANDES Randomized Clinical Trial. CIRCULATION. 2025; 152(25)DOI:10.1161/CIRCULATIONAHA.125.077469. PMID:41139402. IF:38.600(Q1/1D).
01/01/2026 The impact of contractile reserve on clinical outcomes in patients with left ventricular dysfunction undergoing TAVI
Talmor-Barkan, Y, Levi, A, Barbanti, M, Valvo, R, Costa, G, Frittitta, V, De Backer, O, Willemen, Y, van den Dorpel, M, Mon, M, Sugiura, A, Sudo, M, Masiero, G, Pancaldi, E, Arzamendi, D, Garcia-Gomez, M, Baz, JA, Shapira, Y, Steblovnik, K, Mauri, V, Adam, M, Wienemann, H, Zahler, D, Hein, M, Ruile, P, Aodha, BN, Grasso, C, Branca, L, Estevez-Loureiro, R, Amat-Santos, IJ, Mylotte, D, Bunc, M, Tarantini, G, Nombela-Franco, L, Sondergaard, L, Van Mieghem, NM, Finkelstein, A, Kornowski, R, Witberg, G. The impact of contractile reserve on clinical outcomes in patients with left ventricular dysfunction undergoing TAVI. INTERNATIONAL JOURNAL OF CARDIOLOGY. 2026; 442DOI:10.1016/j.ijcard.2025.133916. PMID:40976357. IF:3.200(Q2/3D).
01/10/2025 Telematic intervention on frailty in patients undergoing TAVI. Design of the TELE-FRAIL TAVI clinical trial
Bernal-Labrador, E, Romaguera, R, Garcia-Blas, S, Regueiro, A, Serra, V, Asmarats, L, Tizon-Marcos, H, Agudelo, V, Scardino, C, Casanova-Sandoval, JM, Rodríguez-Gabella, T, Jiménez-Méndez, C, Pérez-Rivera, A, Robles-Gamboa, C, Ayesta, A, Díez-Villanueva, P, Raposeiras-Roubín, S, Amat-Santos, IJ, Esteve-Pastor, A, Veiga-Fernández, G, Anguita, M, Martí-Sánchez, D, Martínez-Velilla, N, Cortés, L, Calvo, E, Asimbaya, S, Formiga, F, Ariza-Solé, A. Telematic intervention on frailty in patients undergoing TAVI. Design of the TELE-FRAIL TAVI clinical trial. REC, interventional cardiology. 2025; 7(4)DOI:10.24875/RECIC.M25000522. PMID:41333125. IF:(Q/D).
01/02/2026 Age-based analysis of the SEC-Excelente-HF registry: clinical characteristics and prognosis of a prospective cohort of heart failure patients
Esteban-Fernández, A, Bonilla-Palomas, JL, Muñiz, J, González-Manzanares, R, Anguita-Gámez, M, Recio-Mayoral, A, Mirabet, S, Cequier, A, García-Orta, R, Anguita-Sánchez, M. Age-based analysis of the SEC-Excelente-HF registry: clinical characteristics and prognosis of a prospective cohort of heart failure patients. European Geriatric Medicine. 2026; 17(1)DOI:10.1007/s41999-025-01392-9. PMID:41442098. IF:3.600(Q2/4D).
01/02/2026 Evaluation of carbohydrate antigen 125 in heart failure with preserved ejection fraction diagnosis
Bagudá, JD, Sánchez, AS, de la Espriella, R, Valero-Masa, MJ, García-Vega, D, Ferrer, MD, de la Cal, TS, Mollar, A, Carmena, MDGC, Martínez-Dolz, L, de la Cruz, J, González-Juanatey, JR, Martínez-Sellés, M, Núñez, J, Jiménez, JFD. Evaluation of carbohydrate antigen 125 in heart failure with preserved ejection fraction diagnosis. HEART. 2026; 112(4)DOI:10.1136/heartjnl-2025-326053. PMID:40877030. IF:4.400(Q1/3D).
01/02/2026 Local modifications in tissular conditions before PFA increases acute lesion size
Amorós-Figueras, G, Casabella-Ramón, S, Moreno-Weidmann, Z, Castellvi, Q, Ivorra, A, García-Sánchez, T, Guerra, JM. Local modifications in tissular conditions before PFA increases acute lesion size. Heart Rhythm O2. 2026; 7(2)DOI:10.1016/j.hroo.2025.11.021. PMID:41732247. IF:(Q/D).
12/08/2025 Gene Expression Pattern Associated with Cytoskeletal Remodeling in Lipid-Loaded Human Vascular Smooth Muscle Cells: Crosstalk Between C3 Complement and the Focal Adhesion Protein Paxillin
Garcia-Arguinzonis, M, Escate, R, Lugano, R, Peña, E, Borrell-Pages, M, Badimon, L, Padro, T. Gene Expression Pattern Associated with Cytoskeletal Remodeling in Lipid-Loaded Human Vascular Smooth Muscle Cells: Crosstalk Between C3 Complement and the Focal Adhesion Protein Paxillin. Cells. 2025; 14(16)DOI:10.3390/cells14161245. PMID:40862724. IF:5.200(Q2/3D).
29/09/2025 Obesity alters VLDL profile and remnant cholesterol differently in metabolically healthy men and women: a 1H-NMR study
Santisteban, V, López-Yerena, A, Muñoz-Garcia, N, Vilahur, G, Badimon, L, Padro, T. Obesity alters VLDL profile and remnant cholesterol differently in metabolically healthy men and women: a 1H-NMR study. Lipids in Health and Disease. 2025; 24(1)DOI:10.1186/s12944-025-02723-2. PMID:41024030. IF:4.200(Q1/3D).
22/01/2026 HDL function and composition in atherothrombotic cardiovascular disease with very high HDL-C
Padro, T, Muñoz-García, N, Fanlo-Maresma, M, Esteve-Luque, V, Cabré-Fernandez, P, Vilahur, G, Riera-Mestre, A, Badimon, L, Pinto, X. HDL function and composition in atherothrombotic cardiovascular disease with very high HDL-C. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2026; 56(1)DOI:10.1111/eci.70159. PMID:41413729. IF:3.600(Q1/2D).
19/08/2025 Established and Emerging Roles of Epigenetic Regulation in Diabetic Cardiomyopathy
Russell-Hallinan, A, Karuna, N, Lezoualc'h, F, Matullo, G, Baker, H, Bernard, M, Devaux, Y, Badimon, L, Vilahur, G, Rieusset, J, Derumeaux, GA, Watson, CJ. Established and Emerging Roles of Epigenetic Regulation in Diabetic Cardiomyopathy. DIABETES-METABOLISM RESEARCH AND REVIEWS. 2025; 41(6)DOI:10.1002/dmrr.70081. PMID:40831067. IF:6.000(Q1/2D).
20/01/2026 Revisiting tricuspid regurgitation: Historical insights and emerging research perspectives
Gonzalez-Cucharero, C, Vilahur, G, Saura, M, Hinojar, R, Zamorano, JL, Zaragoza, C. Revisiting tricuspid regurgitation: Historical insights and emerging research perspectives. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2026; 56(1)DOI:10.1111/eci.70138. PMID:41131691. IF:3.600(Q1/2D).
01/02/2025 Interplay between platelets and coagulation: from protective haemostasis to pathological arterial thrombosis
Vilahur, G, Fuster, V. Interplay between platelets and coagulation: from protective haemostasis to pathological arterial thrombosis. EUROPEAN HEART JOURNAL. 2025; 46(5)DOI:10.1093/eurheartj/ehae776. PMID:39673717. IF:35.600(Q1/1D).
18/09/2023 Lysyl oxidase-dependent extracellular matrix crosslinking modulates calcification in atherosclerosis and aortic valve disease.
Ballester-Servera C, Alonso J, Cañes L, Vázquez-Sufuentes P, Puertas-Umbert L, Fernández-Celis A, Taurón M, Rodríguez-Sinovas A, López-Andrés N, Rodríguez C, Martínez-González J. Lysyl oxidase-dependent extracellular matrix crosslinking modulates calcification in atherosclerosis and aortic valve disease.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2023; 167DOI:10.1016/j.biopha.2023.115469. PMID:37729730. IF:6.900(Q1/1D).
01/03/2026 Cognitive stagnation and executive function deficits in young children with SCN1A+ Dravet syndrome: Detailed characterization of onset, progression, and impact in the ENVISION natural history study
Sullivan, J, Perry, MS, Scheffer, IE, Wheless, J, Boronat, S, Brunklaus, A, Laux, L, Patel, AD, Roberts, C, Dlugos, D, Holder, D, Knupp, K, Lallas, M, Phillips, S, Segal, E, Lal, D, Wirrell, E, Zuberi, S, Gioia, G, Shaffer, R, Berl, MM, Wojnaroski, M, Christensen, S, King, A, James, ES, Vila, MC, Huang, N, Gofshteyn, JS, Rico, S. Cognitive stagnation and executive function deficits in young children with SCN1A+ Dravet syndrome: Detailed characterization of onset, progression, and impact in the ENVISION natural history study. EPILEPSIA. 2026; 67(3)DOI:10.1111/epi.70015. PMID:41251148. IF:6.600(Q1/1D).
01/04/2025 Clinical practice guidelines for the diagnosis and management of Charcot-Marie-Tooth disease.
Sivera Mascaró R, García Sobrino T, Horga Hernández A, Pelayo Negro AL, Alonso Jiménez A, Antelo Pose A, Calabria Gallego MD, Casasnovas C, Cemillán Fernández CA, Esteban Pérez J, Fenollar Cortés M, Frasquet Carrera M, Gallano Petit MP, Giménez Muñoz A, Gutiérrez Gutiérrez G, Gutiérrez Martínez A, Juntas Morales R, Ciano-Petersen NL, Martínez Ulloa PL, Mederer Hengstl S, Millet Sancho E, Navacerrada Barrero FJ, Navarrete Faubel FE, Pardo Fernández J, Pascual Pascual SI, Pérez Lucas J, Pino Mínguez J, Rabasa Pérez M, Sánchez González M, Sotoca J, Rodríguez Santiago B, Rojas García R, Turon-Sans J, Vicent Carsí V, Sevilla Mantecón T. Clinical practice guidelines for the diagnosis and management of Charcot-Marie-Tooth disease.. Neurologia. 2025; 40(3)DOI:10.1016/j.nrleng.2024.02.008. PMID:38431252. IF:(Q/D).
01/04/2026 Analytical and Clinical Validation of Action PharmaKitDx: A Comprehensive NGS Panel for the Identification of Pharmacogenetic Variants in Diverse Populations
Ramudo-Cela, L, Izquierdo-García, M, Dolores-Sequedo, M, Cubells-Perez, V, Bernal, S, Riera, P, Lasa, A, Torres-Juan, L, Asensio, VJ, Martínez-López, I, de Hevia, AO, Morín, M, Moreno-Pelayo, MA, Carmona-Antoñanzas, G, Pelayo, JP. Analytical and Clinical Validation of Action PharmaKitDx: A Comprehensive NGS Panel for the Identification of Pharmacogenetic Variants in Diverse Populations. Pharmaceuticals. 2026; 19(4)DOI:10.3390/ph19040568. PMID:42075824. IF:4.800(Q1/2D).
01/04/2026 Diagnostic yield of chromosomal microarray and virtual targeted gene panel analysis in adults with focal epilepsy: implications for sequential genetic testing strategy
Panadés-de Oliveira, L, Galeote, MS, Duran, EP, Vilella, L, Garcia, ACD, Principe, A, Metje, AP, Marti, IC, Pérez-Jurado, LA, Zucca, R, Boronat, S, Rocamora, R. Diagnostic yield of chromosomal microarray and virtual targeted gene panel analysis in adults with focal epilepsy: implications for sequential genetic testing strategy. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY. 2026; 137DOI:10.1016/j.seizure.2026.02.021. PMID:41785580. IF:2.800(Q2/5D).